- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04901429
Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric Bypass
May 21, 2025 updated by: Baylor Research Institute
The purpose of this study is to investigate the efficacy of performing a truncal vagotomy along with a sleeve to bypass revision surgery in reducing the severity and/or incidence of gastroesophageal reflux disease (GERD) post-surgery.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Research Project Coordinator
- Phone Number: 214-820-4787
- Email: ADVANCEDSURGERYRESEARCH@bswhealth.org
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75246
- Recruiting
- Baylor University Medical Center
-
Contact:
- Research Project Coordinator
- Phone Number: 214-820-4787
- Email: ADVANCEDSURGERYRESEARCH@bswhealth.org
-
Contact:
- Research Manager
- Phone Number: 214-820-1722
- Email: ADVANCEDSURGERYRESEARCH@bswhealth.org
-
Principal Investigator:
- Steven Leeds
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Participating subjects will need to be >18yrs of age and eligible for sleeve to bypass revision bariatric surgery.
- Undergoing sleeve to bypass revision bariatric surgery.
Exclusion Criteria:
- Patients who are under the age of 18.
- Not eligible for sleeve to bypass revision bariatric surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Truncal Vagotomy
Truncal vagotomy will be performed during other routine procedure.
|
Truncal vagotomy will be performed in 50% of patients during other routine procedure.
|
|
No Intervention: No Truncal Vagotomy
No truncal vagotomy will be performed during other routine procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
GERD-HRQL scores
Time Frame: approximately 6 months post operation
|
GERD-HRQL scores
|
approximately 6 months post operation
|
|
Esophageal pH monitoring
Time Frame: approximately 6 months post operation
|
Esophageal pH monitoring
|
approximately 6 months post operation
|
|
Reflux symptom index questionnaire
Time Frame: approximately 6 months post operation
|
Reflux symptom index questionnaire
|
approximately 6 months post operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2028
Study Registration Dates
First Submitted
May 20, 2021
First Submitted That Met QC Criteria
May 20, 2021
First Posted (Actual)
May 25, 2021
Study Record Updates
Last Update Posted (Actual)
May 25, 2025
Last Update Submitted That Met QC Criteria
May 21, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 021-171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on GERD
-
Ohio State UniversityCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalRecruiting
-
Cinclus Pharma Holding ABCompleted
-
Korea United Pharm. Inc.CompletedGERDKorea, Republic of
-
Korea United Pharm. Inc.Completed
-
Chong Kun Dang PharmaceuticalUnknown
-
Turku University HospitalCompleted
Clinical Trials on Truncal vagotomy
-
University of RochesterUniversity of California, San Francisco; EndoVx, Inc.CompletedMorbid ObesityUnited States
-
Central Carolina Surgery, PAEndoVx, Inc.TerminatedHypertension | Diabetes | Urinary Incontinence | Obstructive Sleep Apnea | Hypercholesterolemia | Morbid Obesity | Hypertriglyceridemia
-
University Research Institute for the Study of...National and Kapodistrian University of AthensRecruiting
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes | Weight LossUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedDiabetes | Renal InsufficiencyFrance
-
Riphah International UniversityRecruiting
-
University of Sao PauloEnrolling by invitationHemorrhage | Hypovolemic Shock | TourniquetsBrazil
-
Icahn School of Medicine at Mount SinaiCompletedPostoperative Pain | Intraoperative PainUnited States
-
ElsanCompletedAnesthesia, Local | Carpal Tunnel | Median Nerve NeuralgiaFrance
-
Bezmialem Vakif UniversityCompleted